POP Biotechnologies, Inc.
PrivateLast Round
Grant
Jun 3, 2026
Total Funding Raised
$10.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
POP Biotechnologies, Inc. is a biotechnology company that develops novel therapeutics and vaccines based on its proprietary porphyrin-phospholipid (PoP) liposome technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
POP Biotechnologies, Inc. Comparables
Compare POP Biotechnologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phoreus Biotechnology, Inc. | 87% | |
| Optimeos Life Sciences | 84% | |
| Uvax Bio, LLC | 83% | |
POP Biotechnologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 3, 2026 | ||||
| Grant | Oct 1, 2025 | ||||
| Grant | Jul 24, 2025 | ||||
| Grant | Nov 26, 2024 | ||||
| Grant | Oct 28, 2019 | ||||
Seed | Oct 7, 2015 |
POP Biotechnologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| CEPI | Grant |
| NIH RADx | Grant |
| Z80 Labs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 40% MoM.
- May 19, 2026
Monthly visitors increased 161% MoM, reaching 3.3K.
POP Biotechnologies, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about POP Biotechnologies, Inc.'s valuation, stock price, and market status.